Hospital Universitario Virgen del Rocío -ko ikertzaileekin lankidetzan egindako argitalpenak (39)

2024

  1. Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease

    Journal of Alzheimer's Disease, Vol. 97, Núm. 1, pp. 447-458

  2. Perspectives of Implementation of Closed-Loop Deep Brain Stimulation: From Neurological to Psychiatric Disorders

    Stereotactic and Functional Neurosurgery, Vol. 102, Núm. 1, pp. 40-54

2023

  1. 18F-FDG PET for the diagnosis and assessment of treatment response of autoimmune limbic encephalitis

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 3, pp. 196-197

  2. ARG1-expressing microglia show a distinct molecular signature and modulate postnatal development and function of the mouse brain

    Nature Neuroscience, Vol. 26, Núm. 6, pp. 1008-1020

  3. Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study

    The British journal of psychiatry : the journal of mental science, Vol. 223, Núm. 1, pp. 309-318

  4. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease

    Movement Disorders, Vol. 38, Núm. 5, pp. 755-763

2022

  1. Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation

    Scientific Reports, Vol. 12, Núm. 1

  2. Multi-scale semi-supervised clustering of brain images: Deriving disease subtypes

    Medical Image Analysis, Vol. 75

  3. The HERC proteins and the nervous system

    Seminars in Cell and Developmental Biology, Vol. 132, pp. 5-15

2021

  1. Bold coupling between lesioned and healthy brain is associated with glioma patients’ recovery

    Cancers, Vol. 13, Núm. 19

  2. Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates with Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the Striatum

    Clinical Nuclear Medicine, Vol. 46, Núm. 6, pp. E296-E306

  3. TMA-93 Validation by Alzheimer's Disease Biomarkers: A Comparison with the Free and Cued Selective Reminding Test on a Biobank Sample

    Journal of Alzheimer's Disease, Vol. 82, Núm. 1, pp. 401-410

2020

  1. Differential diagnosis of HaNDL syndrome in a case report of a pediatric patient: The role of SPECT with 99mTc-HMPAO

    eNeurologicalSci, Vol. 19

  2. Impairment of Everyday Spatial Navigation Abilities in Mild Cognitive Impairment Is Weakly Associated with Reduced Grey Matter Volume in the Medial Part of the Entorhinal Cortex

    Journal of Alzheimer's Disease, Vol. 78, Núm. 3, pp. 1149-1159

2019

  1. Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models

    Revista Espanola de Enfermedades Digestivas, Vol. 111, Núm. 4, pp. 301-307

2018

  1. A new stage in the diagnosis of Alzheimer's Disease

    Revista Espanola de Medicina Nuclear e Imagen Molecular

  2. Amyloid PET in neurodegenerative diseases with dementia

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 6, pp. 397-406

2017

  1. A Bayesian spatial model for neuroimaging data based on biologically informed basis functions

    NeuroImage, Vol. 161, pp. 134-148

  2. Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease

    PLoS ONE, Vol. 12, Núm. 4

  3. Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype

    PLoS ONE, Vol. 12, Núm. 3